title: Effect of macrolides on peripheral arterial disease depends on patient selection and adequate treatment.
authors.forename: P-A
authors.initials: PA
authors.lastname: Krayenbuehl
authors.forename: P
authors.initials: P
authors.lastname: Wiesli
authors.forename: T
authors.initials: T
authors.lastname: Meier
authors.forename: G
authors.initials: G
authors.lastname: Schulthess
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D017963:Azithromycin / Q000627:therapeutic use; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use*; D018579:Patient Selection; D016491:Peripheral Vascular Diseases / Q000188:drug therapy; D015575:Roxithromycin / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides; D015575:Roxithromycin; D017963:Azithromycin